SARS-CoV2 Infection Alters Tryptophan Catabolism and Phospholipid Metabolism

Overview

Journal Metabolites

Publisher MDPI

Date 2021 Oct 22

PMID 34677374

Citations 11

Authors

Gagandeep Kaur

Xiangming Ji

Irfan Rahman

Affiliations

Soon will be listed here.

Abstract

Coronavirus disease 2019 (COVID-19) has so far infected hundreds of million individuals, with several million deaths worldwide. The lack of understanding of the disease pathophysiology and the host's immune response has resulted in this rapid spread of the disease on a global scale. In this respect, we employed UPLC-MS to compare the metabolites in the serum from COVID-19-positive patients and COVID-19-recovered subjects to determine the metabolic changes responsible for an infection. Our investigations revealed significant increase in the levels of serum phospholipids including sphingomyelins, phosphatidylcholines and arachidonic acid in the serum of COVID-19-positive patients as compared to COVID-19-recovered individuals. We further show increased levels of tryptophan and its metabolites in the serum of COVID-19-positive patients thus emphasizing the role of tryptophan metabolism in the disease pathogenesis of COVID-19. Future studies are required to determine the changes in the lipid and tryptophan metabolism at various stages of COVID-19 disease development, progression and recovery to better understand the host-pathogen interaction and the long-term effects of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection in humans.

Citing Articles

Navigating SARS-CoV-2-related immunopathology in Crohn's disease: from molecular mechanisms to therapeutic challenges.

Chen C, Lin Y, Liu K, Huang C, Shih C, Lee Y Virol J. 2024; 21(1):288.

PMID: 39538233 PMC: 11562311. DOI: 10.1186/s12985-024-02529-1.

The Link between Inflammation, Lipid Derivatives, and Microbiota Metabolites in COVID-19 Patients: Implications on Eating Behaviors and Nutritional Status.

Hawrylkowicz V, Stasiewicz B, Maciejewska D, Solek-Pastuszka J, Komorniak N, Skonieczna-Zydecka K Int J Mol Sci. 2024; 25(14).

PMID: 39063142 PMC: 11276903. DOI: 10.3390/ijms25147899.

The Potential Role of Hypothalamic Phospholipid Liposomes in the Supportive Therapy of Some Manifestations of Post-COVID-19 Condition: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Brain Fog.

Menichetti F J Clin Med. 2023; 12(17).

PMID: 37685544 PMC: 10488182. DOI: 10.3390/jcm12175478.

Maintained imbalance of triglycerides, apolipoproteins, energy metabolites and cytokines in long-term COVID-19 syndrome patients.

Berezhnoy G, Bissinger R, Liu A, Cannet C, Schafer H, Kienzle K Front Immunol. 2023; 14:1144224.

PMID: 37228606 PMC: 10203989. DOI: 10.3389/fimmu.2023.1144224.

COVID-19, Blood Lipid Changes, and Thrombosis.

Farooqui A, Farooqui T, Sun G, Lin T, Teh D, Ong W Biomedicines. 2023; 11(4).

PMID: 37189799 PMC: 10135929. DOI: 10.3390/biomedicines11041181.

References

Ellinghaus D, Degenhardt F, Bujanda L, Buti M, Albillos A, Invernizzi P . Genomewide Association Study of Severe Covid-19 with Respiratory Failure. N Engl J Med. 2020; 383(16):1522-1534. PMC: 7315890. DOI: 10.1056/NEJMoa2020283. View

Iida M, Harada S, Takebayashi T . Application of Metabolomics to Epidemiological Studies of Atherosclerosis and Cardiovascular Disease. J Atheroscler Thromb. 2019; 26(9):747-757. PMC: 6753246. DOI: 10.5551/jat.RV17036. View

Schmidt S, Schultze J . New Insights into IDO Biology in Bacterial and Viral Infections. Front Immunol. 2014; 5:384. PMC: 4128074. DOI: 10.3389/fimmu.2014.00384. View

DAlessandro A, Thomas T, Dzieciatkowska M, Hill R, Francis R, Hudson K . Serum Proteomics in COVID-19 Patients: Altered Coagulation and Complement Status as a Function of IL-6 Level. J Proteome Res. 2020; 19(11):4417-4427. PMC: 7640953. DOI: 10.1021/acs.jproteome.0c00365. View

Ambre J, Ruo T, Smith G, Backes D, Smith C . Ecgonine methyl ester, a major metabolite of cocaine. J Anal Toxicol. 1982; 6(1):26-9. DOI: 10.1093/jat/6.1.26. View

Roth M, Connett J, DArmiento J, Foronjy R, Friedman P, Goldin J . Feasibility of retinoids for the treatment of emphysema study. Chest. 2006; 130(5):1334-45. DOI: 10.1378/chest.130.5.1334. View

Das U . Can Bioactive Lipids Inactivate Coronavirus (COVID-19)?. Arch Med Res. 2020; 51(3):282-286. PMC: 7270578. DOI: 10.1016/j.arcmed.2020.03.004. View

Guijas C, Montenegro-Burke J, Domingo-Almenara X, Palermo A, Warth B, Hermann G . METLIN: A Technology Platform for Identifying Knowns and Unknowns. Anal Chem. 2018; 90(5):3156-3164. PMC: 5933435. DOI: 10.1021/acs.analchem.7b04424. View

Barberis E, Timo S, Amede E, Vanella V, Puricelli C, Cappellano G . Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2. Int J Mol Sci. 2020; 21(22). PMC: 7696386. DOI: 10.3390/ijms21228623. View

10.

Sorgdrager F, Naude P, Kema I, Nollen E, De Deyn P . Tryptophan Metabolism in Inflammaging: From Biomarker to Therapeutic Target. Front Immunol. 2019; 10:2565. PMC: 6833926. DOI: 10.3389/fimmu.2019.02565. View

11.

Carlin J, Borden E, Byrne G . Interferon-induced indoleamine 2,3-dioxygenase activity inhibits Chlamydia psittaci replication in human macrophages. J Interferon Res. 1989; 9(3):329-37. DOI: 10.1089/jir.1989.9.329. View

12.

Harvey W, Carabelli A, Jackson B, Gupta R, Thomson E, Harrison E . SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol. 2021; 19(7):409-424. PMC: 8167834. DOI: 10.1038/s41579-021-00573-0. View

13.

Kaur G, Yogeswaran S, Muthumalage T, Rahman I . Persistently Increased Systemic ACE2 Activity Is Associated With an Increased Inflammatory Response in Smokers With COVID-19. Front Physiol. 2021; 12:653045. PMC: 8194708. DOI: 10.3389/fphys.2021.653045. View

14.

Belladonna M, Orabona C . Potential Benefits of Tryptophan Metabolism to the Efficacy of Tocilizumab in COVID-19. Front Pharmacol. 2020; 11:959. PMC: 7319082. DOI: 10.3389/fphar.2020.00959. View

15.

Cheng S, Shah S, Corwin E, Fiehn O, Fitzgerald R, Gerszten R . Potential Impact and Study Considerations of Metabolomics in Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association. Circ Cardiovasc Genet. 2017; 10(2). PMC: 6001363. DOI: 10.1161/HCG.0000000000000032. View

16.

Shoieb S, El-Ghiaty M, El-Kadi A . Targeting arachidonic acid-related metabolites in COVID-19 patients: potential use of drug-loaded nanoparticles. Emergent Mater. 2020; 4(1):265-277. PMC: 7670111. DOI: 10.1007/s42247-020-00136-8. View

17.

Li P, Yin Y, Li D, Kim S, Wu G . Amino acids and immune function. Br J Nutr. 2007; 98(2):237-52. DOI: 10.1017/S000711450769936X. View

18.

Lionetto L, Ulivieri M, Capi M, De Bernardini D, Fazio F, Petrucca A . Increased kynurenine-to-tryptophan ratio in the serum of patients infected with SARS-CoV2: An observational cohort study. Biochim Biophys Acta Mol Basis Dis. 2020; 1867(3):166042. PMC: 7834629. DOI: 10.1016/j.bbadis.2020.166042. View

19.

Schmitz J, Carlin J, Borden E, Byrne G . Beta interferon inhibits Toxoplasma gondii growth in human monocyte-derived macrophages. Infect Immun. 1989; 57(10):3254-6. PMC: 260802. DOI: 10.1128/iai.57.10.3254-3256.1989. View

20.

Mehraj V, Routy J . Tryptophan Catabolism in Chronic Viral Infections: Handling Uninvited Guests. Int J Tryptophan Res. 2015; 8:41-8. PMC: 4527356. DOI: 10.4137/IJTR.S26862. View